|
Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2–negative Metastatic Breast Cancer |
|
|
|
Titel: |
Phase II Study of Eribulin Mesylate Administered Biweekly in Patients With Human Epidermal Growth Factor Receptor-2–negative Metastatic Breast Cancer |
Auteur: |
Smith II, John Irwin, Amy Jensen, Lori Tedesco, Karen Misir, Soamnauth Zhu, Wei Almonte, Ana He, Yaohua Xie, Ran Olivo, Martin O’Shaughnessy, Joyce |
Verschenen in: |
Clinical breast cancer |
Paginering: |
Jaargang 20 () nr. 2 pagina's 160-167 |
Jaar: |
2020 |
Inhoud: |
|
Uitgever: |
The Authors |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|